These studies demonstrated that IL-2 secretion from CD3+ T cells was reduced in the presence of tumor cells expressing high levels of PD-L1, but could be restored through addition of PD1-Fc-OX40L (Fig. 4b). Here, IL2 is linked to neoplasm.